Data from this study provide base rate information for planning pleasant event interventions in nursing homes. The PES-NH is a useful and valid tool for implementing behavioral interventions for depression in these settings.

No abstract

Introduction The object of this study1 was to provide an updated evaluation of the quality of antidepressant management and prescribing patterns in nursing homes in the context of organizational and resident factors. Design Pearson correlation and chi-square analyses were conducted using information gathered from random nursing home charts. Setting Nursing home facilities in and around the Louisville, KY metropolitan area (N = 10). Participants Chart reviews were randomly chosen for 20% of long-term care resident records in participating homes (N = 209). Measurements Demographic information, documentation of depression diagnoses and antidepressant prescribing patterns were evaluated using the Quality of Depression Management and Antidepressant Prescribing rating (QDMAP) scale and information found the Minimum Data Set 2.0. Results 59.8% of the sample was prescribed antidepressants at the time of the chart review. 205 chart reviews indicated the absence or presence of a depression diagnosis, For those with documented depression diagnoses (n=126), nearly one quarter were not prescribed antidepressants. Out of 79 chart reviews indicating no depression diagnosis, nearly a third were receiving an antidepressant. Documentation related to changes in dosing, the presence or absence of side effects, or reasons for continuation were suboptimal. Conclusion Discrepancy between antidepressant prescribing and the presence/absence of depression diagnoses continue to exist for nursing home residents. The quality of antidepressant documentation in nursing home charts continues to be inadequate. Future research should aim to explore possible solutions to these discrepancies and deficiencies in documentation.

There were mixed findings supporting the construct validation of CG. A comprehensive framework that emphasizes pre-bereavement circumstances was proposed in order to better predict various grief trajectories and outcomes of late-life loss.

Prolactin is a polypeptide hormone that is well known for its role in reproductive physiology. Recent studies highlight its role in neurohormonal appetite regulation and metabolism. Elevated prolactin levels are widely associated with worsening metabolic disease, but it appears that low prolactin levels could also be metabolically unfavorable. This review discusses the pathophysiology of prolactin related metabolic changes, and the less commonly recognized effects of prolactin on adipose tissue, pancreas, liver, and small bowel. Furthermore, the effect of dopamine agonists on the metabolic profiles of patients with hyperprolactinemia are discussed as well.